05:58 PM EDT, 03/22/2024 (MT Newswires) -- Jeffrey W. Albers, Director, on March 20, 2024, sold 25,073 shares in Blueprint Medicines ( BPMC ) for $2,188,265. Following the Form 4 filing with the SEC, Albers has control over a total of 176,050 shares of the company, with 176,050 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1597264/000141588924009009/xslF345X03/form4-03222024_090329.xml